Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome
1996

Glutathione-S-transferase Activity in Ovarian Cancer

Sample size: 97 publication Evidence: low

Author Information

Author(s): EC Wrigley, AT McGown, H Buckley, A Hall, D Crowther

Primary Institution: University of Manchester, Christie Hospital NHS Trust

Hypothesis

The study investigates the correlation between glutathione-S-transferase isoenzyme levels and disease outcomes in ovarian cancer.

Conclusion

The study found that glutathione-S-transferase isoenzyme levels and activity are not reliable markers for predicting disease outcome or survival in ovarian cancer patients.

Supporting Evidence

  • Glutathione-S-transferase isoenzyme levels were correlated with overall and progression-free survival.
  • Immunohistochemistry and Western blot methods showed consistency in detecting isoenzyme levels.
  • Clinicopathological features like FIGO stage and residual disease were significant markers of survival.

Takeaway

This study looked at certain proteins in ovarian cancer to see if they could help predict how well patients would do, but they didn't find any useful connections.

Methodology

The study measured glutathione-S-transferase isoenzyme levels in ovarian tumor biopsies using immunohistochemistry and Western blot methods, correlating results with clinical outcomes.

Potential Biases

Potential observer variation in immunohistochemistry and dilution of tumor protein in homogenates may introduce bias.

Limitations

The study was limited by the availability of follow-up data and the small number of sequential samples for analysis.

Participant Demographics

The study included 97 patients with ovarian cancer, with biopsies taken before and after chemotherapy.

Statistical Information

P-Value

P=0.034

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication